Kadmon will form a life sciences venture with Nano Terra

04/25/2011 | Xconomy · Genetic Engineering & Biotechnology News

Nano Terra and Kadmon Pharmaceuticals intend to create a joint venture, NT Life Sciences, to work on the former's Pharmacomer drug-discovery platform and three of its enzyme-targeting compounds. Kadmon will have exclusive global rights to the investigational drugs and the technology.

View Full Article in:

Xconomy · Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC